HX301 Monolactate Capsules

HX301 monolactate · Hangzhou Hanx Biopharmaceuticals, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HX301 Monolactate Capsules, covering 2024-06-18 to 2024-06-18. Get the full timeline:

Most recent: Clinical Trial Update: The Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors [Phase 1]

See pricing